Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
-
Narrado por:
-
De:
Join guest host Dr. Liz Specht for a conversation with Matt Spence, the managing director and global head of venture capital banking at Barclays. In this episode Dr. Spence discusses the role food security plays in national security and how the government can incentivize and support biotechnology research and development. The episode explores how synthetic biology can be leveraged into additional defense uses and dispels common misconceptions about synthetic biology and national security.
To receive updates about the conference please join our mailing list here: https://www.emergingtechnologiesinstitute.org/sign-uphttp://emergingtechnologiesinstitute.orghttps://www.facebook.com/EmergingTechETIhttps://www.linkedin.com/company/ndia-eti-emerging-technologies-institutehttps://www.twitter.com/EmergingTechETI